Cleare AJ

Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

6 papers · ORCID

ArticleKetamine

Improvements in health-related quality of life with esketamine nasal spray versus quetiapine extended release.

Reif A, Baune BT, Buyze J +8

Europe PMC2025
ArticleKetamine

Improvements in functioning and workplace productivity with esketamine nasal spray versus quetiapine extended release in patients with treatment resistant depression: Findings from a 32-week randomised, open-label, rater-blinded phase IIIb study.

Vieta E, Ahmed N, Arango C +11

Europe PMC2025
ArticleKetamine

Is there a risk of addiction to ketamine during the treatment of depression? A systematic review of available literature.

Ingrosso G, Cleare AJ, Juruena MF

Europe PMC2025
ArticlePsilocybin

Predicting the Intensity of Psychedelic-Induced Mystical and Challenging Experience in a Healthy Population: An Exploratory Post-Hoc Analysis.

Ko K, Carter B, Cleare AJ +1

Europe PMC2023
ArticlePsilocybin

Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis.

Ko K, Kopra EI, Cleare AJ +1

Europe PMC2023
ArticlePsilocybin

Psychedelics, Mystical Experience, and Therapeutic Efficacy: A Systematic Review.

Ko K, Knight G, Rucker JJ +1

Europe PMC2022